Research firm targets COPD
By HME News Staff
Updated Thu April 18, 2013
DUBLIN, Ireland - Research and Markets, a source for market analysis and reports, now offers a market overview for chronic obstructive pulmonary disease (COPD), according to a press release. The report, entitled “Chronic Obstruct Pulmonary Disease (COPD): Market, Treatment, and Development Overview,” examines the economic burden of COPD, while studying ways in which healthcare companies can make substantial economic gains by introducing new methods of treatment. The COPD market, currently dominated by a few therapies, is about to experience significant transformation, the report says. “The substantial unmet need associated with the disease creates significant market potential for players in the field,” the release said. About 12 million Americans have been diagnosed with COPD, with another 12 million undiagnosed, according to estimates.
Comments